Literature DB >> 27531188

Objective efficacy of the tension-free vaginal tape in obese/morbidly obese women versus non-obese women, at median five year follow up.

Joanne B McKenna1, Katrina Parkin1, Ying Cheng2, Kate H Moore1,2.   

Abstract

BACKGROUND: One subjective long-term evaluation of the tension-free vaginal tape (TVT) success rate in obese women showed a worse prognosis in the obese, but objective studies have been limited to short-term follow-up (less than two years). AIM: To determine whether the long-term objective cure rate in obese/morbidly obese women who underwent TVT was reduced, compared to non-obese women (at five or more years).
MATERIALS AND METHODS: Body mass index (BMI) was collected on patients undergoing TVT procedure. Recruited patients were asked to perform a 24 h pad test and complete an International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) at five years postoperatively. Data was analyzed according to pre-operative urodynamic diagnoses and BMI, using 'routine' and 'strict' objective definitions of objective cure.
RESULTS: At median follow-up of 64 months (interquartile range 58-80 months), 136 patients returned a pad test and ICIQ-SF. Using a routine definition of cure (pad test of ≤10 g in a 24 h period), 96% of patients were cured overall. The BMI results (n = 119 patients) were stratified into ≤25, 25.1-35 and ≥35.1 kg/m2 , which represented 41, 53 and 6% of patients, respectively. The routine cure rates for these three groups were 98, 97 and 71%, respectively (P = 0.004).
CONCLUSION: Long-term objective outcomes of the TVT in morbidly obese women are significantly poorer than in women with a normal BMI.
© 2016 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Long-term follow up; morbid obesity; obesity; stress urinary incontinence; tension-free vaginal tape

Mesh:

Year:  2016        PMID: 27531188     DOI: 10.1111/ajo.12516

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  5 in total

Review 1.  Obesity and Stress Urinary Incontinence: Impact on Pathophysiology and Treatment.

Authors:  Alex Fuselier; Jordan Hanberry; J Margaret Lovin; Alex Gomelsky
Journal:  Curr Urol Rep       Date:  2018-02-22       Impact factor: 3.092

2.  Impact of severe obesity on long-term success and complications of the retropubic midurethral sling.

Authors:  Nicola Dykes; Lynsey Hayward; Christin Coomarasamy
Journal:  Int Urogynecol J       Date:  2020-07-06       Impact factor: 2.894

3.  The impact of overweight in the efficiency and complications of midurethral sling in patients with stress urinary incontinence: a systematic review and meta-analysis.

Authors:  Yi Sun; Guo-Lin Lei; Cai Tang; Lu Yang; Hong Shen; Qiang Wei
Journal:  Int Urol Nephrol       Date:  2018-07-14       Impact factor: 2.370

Review 4.  Outcomes collected in female pelvic floor surgical procedure registries and databases: a scoping review.

Authors:  Rasa Ruseckaite; Justin O Daly; Joanne Dean; Susannah Ahern
Journal:  Int Urogynecol J       Date:  2021-05-26       Impact factor: 2.894

5.  Demographic risk factors for mid-urethral sling failure. Do they really matter?

Authors:  Wojciech Majkusiak; Andrzej Pomian; Edyta Horosz; Aneta Zwierzchowska; Paweł Tomasik; Wojciech Lisik; Ewa Barcz
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.